课题基金 / 基金详情

Using a combined approach of meta-analysis and pharmacoepidemiology to assess the safety of SGLT2 inhibitors (sodium-glucose cotransporter 2)

Using a combined approach of meta-analysis and pharmacoepidemiology to assess the safety of SGLT2 inhibitors (sodium-glucose cotransporter 2)
使用荟萃分析和药物流行病学相结合的方法评估 SGLT2 抑制剂（钠-葡萄糖协同转运蛋白 2）的安全性
批准号：
383315
负责人：
Fralick Michael P
金额：
$7.65万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-10-01 至 2020-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=383315&lang=en
关键词：
Clinical Epidemiology Pharmacoepidemiology

项目摘要

项目成果

Fralick Michael P的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Approximately 15% of people living in Canada have type 2 diabetes mellitus ('diabetes'). Patients with diabetes have abnormally high levels of glucose in their blood. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral medications th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Surveillance of Healthcare and Ambient Pathogens in our Environments and Spaces [SHAPES]
Surveillance of Healthcare and Ambient Pathogens in our Environments and Spaces [SHAPES]
海外基金